tiprankstipranks
Stocks
Top Analyst Stocks
Popular
Top Smart Score Stocks
Popular
AI Analyst Top Stocks
New
Top Insiders StocksMarket MoversTipRanks 50 IndexAI StocksLargest Companies by Market Cap
ETFs
Top ETFs by UpsideTop ETFs by Smart ScoreTop Gainers/ Losers/ Active ETFs
Crypto
Bitcoin
Popular
Ethereum
Commodities
Gold
Options
Unusual Options Activity
Popular
Currency
EUR/USD
Research Tools
Trending StocksCompare StocksCompare ETFsTrump Dashboard
New
Daily Feeds
Daily Analyst RatingsDaily Insider Trading Tracker
Calendars
Earnings CalendarDividend CalendarEconomic CalendarIPO CalendarStock SplitsStock BuybacksMarket Holidays
Calculators
Dividend CalculatorDividend Yield CalculatorOptions Profit Calculator
Economic Indicators
Inflation RateUnemployment Rate
Class Actions
Stock ScreenerETF Screener
Popular
Penny Stock ScreenerTechnical Analysis Screener
Dividend CenterBest Dividend Stocks
Popular
Best High Yield Dividend StocksDividend AristocratsDividend Stock Comparison
New
Dividend CalculatorDividend Returns ComparisonDividend Calendar
My ExpertsTop AnalystsTop Financial BloggersTop-Performing Corporate InsidersTop Hedge Fund ManagersTop Research FirmsTop Individual Investors
Trending News
More News >
Education
Personal FinanceHow To Use TipRanksTipRanks LabsGlossaryFAQs
About Us
About TipRanksContact UsCareersReviewsMobile APP
Working with TipRanks
Enterprise SolutionsAdvertise with UsTop Online BrokersBecome an AffiliateTipRanks News Wire
Follow Us
TOOLS
Portfolio
Watchlist
Top Insiders Stocks
Popular
Top Stocks
Popular
Market Movers
Compare stocks
Compare ETFs
Notification Center
News
Stock Screener
ETF Screener
Popular
Penny Stock Screener
Technical Analysis Screener
Top Analyst Stocks
Popular
Top Smart Score Stocks
Popular
AI Analyst Top Stocks
New
Top Insiders Stocks
Compare Stocks
Compare ETFs
Trending Stocks
Daily Analyst Ratings
Daily Insiders Trades
Dividend Stocks
ETF Center
Top Gainers/losers/active ETFs
Trump Dashboard
New
Dividend Calculator
Options Profit Calculator
Dollar Cost Averaging
Compound Interest Calculator
Mortgage Calculator
Auto Loan Calculator
Student Loan Calculator
401k Retirement Calculator
Earnings Calendar
Dividend Calendar
Economic Calendar
IPO Calendar
Stock Splits
Stock Buybacks
Market Holidays
Dividend Center
Best Dividend Stocks
Popular
Best High Yield Dividend Stocks
Dividend Aristocrats
Dividend Stock Comparison
New
Dividend Calculator
Dividend Returns Comparison
Dividend Calendar
Top Analysts
Top Financial Bloggers
Top-Performing Corporate Insiders
Top Hedge Fund Managers
Top Research Firms
Top Individual Investors
Top Gainers
Top Losers
Most Active
Premarket
After-hours
Personal Finance Center
Mortgages
Loans
Investing & Retirement
Spending & Savings
Real Estate
Top Online Brokers
Enterprise Solutions
Plans & Pricing
Education
How To Use TipRanks
TipRanks Labs
Glossary
FAQs
About Us
About TipRanks
Contact Us
Careers
Reviews
Mobile APP
Working with TipRanks
Enterprise Solutions
Top Online Brokers
Become an Affiliate
TipRanks News Wire
Follow Us
STOCKS
SPY
QQQ
AAPL
NVDA
TSLA
AMZN
BABA
Advertisement
Advertisement

DE:6BG Stock Latest News

Lytix Biopharma’s Partner to Present Promising Phase II Trial Data at SITC
Company AnnouncementsLytix Biopharma’s Partner to Present Promising Phase II Trial Data at SITC
6d ago
6BG
Lytix Biopharma Strengthens Management Incentives with Share Options
PremiumCompany Announcements
Lytix Biopharma Strengthens Management Incentives with Share Options
1M ago
6BG
Lytix Biopharma Advances Ruxotemitide in Cancer Treatment with Promising H1 2025 Results
PremiumCompany Announcements
Lytix Biopharma Advances Ruxotemitide in Cancer Treatment with Promising H1 2025 Results
2M ago
6BG
Lytix Biopharma to Announce Q2 2025 Financial Results
PremiumCompany Announcements
Lytix Biopharma to Announce Q2 2025 Financial Results
2M ago
6BG
Lytix Biopharma Grants Share Options to Board Members
PremiumCompany Announcements
Lytix Biopharma Grants Share Options to Board Members
5M ago
6BG
Lytix Biopharma Reports Strong Q1 2025 Results and Strategic Advancements
PremiumCompany AnnouncementsLytix Biopharma Reports Strong Q1 2025 Results and Strategic Advancements
5M ago
6BG
Lytix Biopharma Strengthens Board to Boost Immuno-Oncology Focus
Premium
Company Announcements
Lytix Biopharma Strengthens Board to Boost Immuno-Oncology Focus
6M ago
6BG
Lytix Biopharma Announces Board Chair Resignation Amid Strategic Developments
Premium
Company Announcements
Lytix Biopharma Announces Board Chair Resignation Amid Strategic Developments
6M ago
6BG
Lytix Biopharma Announces Annual General Meeting Amidst Cancer Treatment Innovations
PremiumCompany Announcements
Lytix Biopharma Announces Annual General Meeting Amidst Cancer Treatment Innovations
6M ago
6BG
Lytix Biopharma’s LTX-315 Shows Promising Results as It Eyes Phase III Trials
PremiumCompany Announcements
Lytix Biopharma’s LTX-315 Shows Promising Results as It Eyes Phase III Trials
8M ago
6BG
Lytix Biopharma Secures U.S. Patent for Cancer Therapy
PremiumCompany Announcements
Lytix Biopharma Secures U.S. Patent for Cancer Therapy
8M ago
6BG
Lytix Biopharma to Announce Q4 2024 Financial Results
PremiumCompany Announcements
Lytix Biopharma to Announce Q4 2024 Financial Results
8M ago
6BG
Lytix Biopharma’s LTX-315 Shows Promising Results in BCC Treatment
PremiumCompany AnnouncementsLytix Biopharma’s LTX-315 Shows Promising Results in BCC Treatment
9M ago
6BG
Lytix Biopharma Completes Capital Raise of NOK 111.3 Million
Premium
Company Announcements
Lytix Biopharma Completes Capital Raise of NOK 111.3 Million
9M ago
6BG
Lytix Biopharma Halts Additional Share Offering After Successful Fundraising
Premium
Company Announcements
Lytix Biopharma Halts Additional Share Offering After Successful Fundraising
9M ago
6BG
Lytix Biopharma Secures NOK 111.3 Million Funding
PremiumCompany Announcements
Lytix Biopharma Secures NOK 111.3 Million Funding
10M ago
6BG
Lytix Biopharma Increases Capital for Cancer Innovations
PremiumCompany Announcements
Lytix Biopharma Increases Capital for Cancer Innovations
10M ago
6BG
Lytix Biopharma Secures NOK 111.3 Million Funding
PremiumCompany Announcements
Lytix Biopharma Secures NOK 111.3 Million Funding
10M ago
6BG
Lytix Biopharma Raises Capital to Fast-Track Drug Development
PremiumCompany Announcements
Lytix Biopharma Raises Capital to Fast-Track Drug Development
10M ago
6BG
Lytix Biopharma AS Launches New Share Offering
PremiumCompany AnnouncementsLytix Biopharma AS Launches New Share Offering
10M ago
6BG
Lytix Biopharma’s Promising Advances in Cancer Treatment
Premium
Company Announcements
Lytix Biopharma’s Promising Advances in Cancer Treatment
11M ago
6BG
Lytix Biopharma Partner Raises $42M in Public Offering
Premium
Company Announcements
Lytix Biopharma Partner Raises $42M in Public Offering
11M ago
6BG

Trending

Name
Price
Price Change
SPX
S&P 500
DJIA
Dow Jones
NDX
Nasdaq 100
More Trending Stocks >